Search
文章正文
Moderna COVID-19 booster gives 'significantly higher' antibody response among elderly with Pfizer-BioNTech vaccination: NCID study
Published:2022-03-17 16:06:46    Text Size:【BIG】【MEDIUM】【SMALL

SINGAPORE: Interim findings by the National Centre for Infectious Diseases (NCID) have shown that a Moderna COVID-19 booster shot will give older adults a "significantly higher" antibody response.

The findings were based on a clinical trial conducted on 100 participants who had received the Pfizer-BioNTech/Comirnaty shot as their primary series of COVID-19 vaccination. Half were aged under 60 years old, the other half above 60, with two eventually dropping out of the study.

Search
脚注信息
Copyright(C)2009-2012 Electronic equipment company
脚注栏目